Samalin Investment Counsel, LLC Jazz Pharmaceuticals PLC Transaction History

Samalin Investment Counsel, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $6,431 - $9,239	-50 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$160.2 - $186.42 $8,009 - $9,321	50 New	50 $8,000
Q1 2021 May 11, 2021	SELL	$150.19 - $173.5 $7,509 - $8,675	-50 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$105.46 - $144.13 $5,273 - $7,206	50 New	50 $7,000
Q1 2020 May 04, 2020	SELL	$87.74 - $152.74 $4,387 - $7,637	-50 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$117.65 - $153.73 $5,882 - $7,686	50 New	50 $7,000

513

57.7M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.